Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Use of Eicosanoids to Enhance Donor Cell Engraftment after in Utero Hematopoietic Cell Transplantation (IUHCT)

Matthew M Boelig, MD, Jacqueline Tsai, MD, Aimee G Kim, MD, Michael A Conner, Stavros Loukogeorgakis, MBBS, BSc, PhD, Haiying Li, Pulin Li, PhD, Leonard I. Zon, MD, Alan W Flake, MD, William H Peranteau, MD

Blood (2015) 126 (23): 35.

https://doi.org/10.1182/blood.V126.23.35.35

Published: 2015

Journal Articles

Prostaglandin E2 Provides a Selective Donor Cell Competitive Advantage and Improves Long-Term Engraftment After in Utero Hematopoietic Cell Transplantation.

Jacqueline Tsai, MD, Jesse D Vrecenak, MD, Jason Sulkowski, MD, Yan Li, MD, PhD, Alan W Flake, MD

Blood (2012) 120 (21): 2993.

https://doi.org/10.1182/blood.V120.21.2993.2993

Published: 2012

Journal Articles

Altered Thymocyte Development in Allogeneic in Utero Hematopoietic Cell Transplantation in the Mouse Model

Yan Li, MD, PhD, Jesse D Vrecenak, MD, Miho Watanabe, MD, PhD, Haiying Li, Jacqueline Tsai, MD, William Peranteau, M.D., Alan W Flake, MD

Blood (2012) 120 (21): 4668.

https://doi.org/10.1182/blood.V120.21.4668.4668

Published: 2012

Journal Articles

Preconditioning with AMD3100 Mobilization Promotes Homing and Long-Term Engraftment of Hematopoietic Stem Cells During Syngeneic Transplantation in the Murine Model

Yan Li, Ph.D., Jacqueline Tsai, MD, Jason Sulkowski, MD, Haiying Li, William Peranteau, M.D., Alan W Flake, MD

Blood (2012) 120 (21): 1886.

https://doi.org/10.1182/blood.V120.21.1886.1886

Published: 2012

Journal Articles

Acute Gvhd Induced by In Utero Hematopoietic Cell Transplantation Is Reversed by a Regulatory Response Resulting in a Potent Graft Vs. Hematopoietic Effect without Clinical Gvhd

Miho Watanabe, MD, PhD, Jesse Vrecenak, MD, Jacqueline Tsai, MD, Jason Sulkowski, MD, Edem Timpo, MD, Haying Li, BS, Alan W Flake, MD

Blood (2011) 118 (21): 1904.

https://doi.org/10.1182/blood.V118.21.1904.1904

Published: 2011

NARROW

The Use of Eicosanoids to Enhance Donor Cell Engraftment after in Utero Hematopoietic Cell Transplantation (IUHCT)

Prostaglandin E2 Provides a Selective Donor Cell Competitive Advantage and Improves Long-Term Engraftment After in Utero Hematopoietic Cell Transplantation.

Altered Thymocyte Development in Allogeneic in Utero Hematopoietic Cell Transplantation in the Mouse Model

Preconditioning with AMD3100 Mobilization Promotes Homing and Long-Term Engraftment of Hematopoietic Stem Cells During Syngeneic Transplantation in the Murine Model

Acute Gvhd Induced by In Utero Hematopoietic Cell Transplantation Is Reversed by a Regulatory Response Resulting in a Potent Graft Vs. Hematopoietic Effect without Clinical Gvhd

Email alerts

ASH Publications

American Society of Hematology

The Use of Eicosanoids to Enhance Donor Cell Engraftment after in Utero Hematopoietic Cell Transplantation (IUHCT)

Prostaglandin E2 Provides a Selective Donor Cell Competitive Advantage and Improves Long-Term Engraftment After in Utero Hematopoietic Cell Transplantation.

Altered Thymocyte Development in Allogeneic in Utero Hematopoietic Cell Transplantation in the Mouse Model

Preconditioning with AMD3100 Mobilization Promotes Homing and Long-Term Engraftment of Hematopoietic Stem Cells During Syngeneic Transplantation in the Murine Model

Acute Gvhd Induced by In Utero Hematopoietic Cell Transplantation Is Reversed by a Regulatory Response Resulting in a Potent Graft Vs. Hematopoietic Effect without Clinical Gvhd

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only